Published on 16 May 2024 on GuruFocus.com via Yahoo Finance
On May 14, 2024, David Guyer, Director at EyePoint Pharmaceuticals Inc (NASDAQ:EYPT), executed a sale of 11,625 shares of the company. The transaction was filed on the same day with the SEC. Following this transaction, the insider has sold a total of 11,625 shares over the past year, with no recorded purchases.
Warning! GuruFocus has detected 3 Warning Signs with EYPT.